ADAMTS13 and Cognitive impairment: Due to the small sample size, it was not possible to establish a relationship between the volumetric reduction of the CNS and other important factors, such as ADAMTS13 deficiency, comorbidities, presence or absence of anti-ADAMTS13 antibodies, cognitive impairment, depression or other neurological involvement.